Biotin Price Trend Analysis 2026: Latest News, Historical Prices, Price Drivers, Market Insights & Supply Demand Analysis

Biotin finds broad application in human health in supplements that aim at hair, skin, and metabolic health. Downstream consumption from these industries kept the market driven for biotin.

During the second quarter of 2025, the demand from the abovementioned sectors still continued to shape buying habits. Producers and traders saw a steady flow of orders from the personal care and wellness industries. However, buyers during the same period remained cautious and preferred only near-term buying, having started the quarter with comfortable inventories carried over from earlier periods this year.

The trend of prices for Biotin was characterized by small, short-term fluctuations instead of a consistent trend. While some buyers started accumulating inventory, small shortages were seen briefly, but the producers soon filled these gaps with new supply.

As new suppliers came into the market, sellers competed harder, and this restricted price fluctuations which remained range bound. Volumes traded remained moderate, and sellers and buyers alike avoided making long-term commitments. The market ended the quarter with Biotin prices having experienced only temporary minor movements with no dramatic surge.

Analyst Insight

According to Procurement Resource, near-term supply is expected to remain comfortable, and there are no clear signals of major shifts ahead for the Biotin market.

Biotin is increasingly used nowadays in animal feeds, human dietary supplements, and cosmetics. It is used because it promotes healthy metabolism, improves hair and nails, and plays a crucial role in growth and productivity in poultry and livestock.

In the first quarter of 2025, the biotin price curve witnessed an oscillating trajectory across the globe. Buying was subdued, as purchasers believed that the huge supply in the market would prevent prices from advancing much. Some traders made effort to build short-run stocks only left limited, temporary gaps in supply, which manufacturers promptly filled. Entry of a new supplier introduced competition and prompted incumbent producers to handle their production cautiously, contributing further to the perception of an equilibrium market.

Prices fluctuated slightly, with no significant rushes of purchases from any sector. Animal feed and supplement sectors held to scheduled patterns of buying, and no region evidenced sudden changes in usage. Any temporary shortage of supply was speedily alleviated, since inventories were well controlled and supplies of new product continued at a steady pace.

In Q4’24, Biotin prices experienced an upward trend due to a combination of increasing demand and tightening supply. This was particularly evident in Europe and the U.S., where various factors contributed to the price surge. In Europe, Biotin prices saw a rise as consumer sentiment improved, spurred by a stable economic outlook and a drop in inflation. This shift in consumer behaviour led to higher demand for products like Biotin, which, in turn, put upward pressure on prices. Additionally, the approach of China’s Golden Week holiday led to businesses rushing shipments before potential delays caused by factory closures and slower port operations, further contributing to the price rise.

In the U.S., the rise in Biotin prices was largely due to heightened consumer confidence, which led to stronger demand across the market. Retailers also took proactive measures in response to the risk of labour strikes on the East and Gulf Coast ports, leading to increased stockpiling of Biotin to ensure supply continuity. This pre-emptive action, coupled with strong demand, created additional strain on the already-constrained supply chains, driving prices higher.

The prices of biotin fluctuated but remained within a defined range during the third quarter of 2024. For most of the three-month period, prices were steady, with occasional fluctuations caused by supply disruptions, and logistical challenges. Biotin prices had been low for an extended period, allowing buyers to secure supplies at lower rates.

Downstream industries such as supplements and skincare had already purchased stock and built inventories, leading to a dip in buying activity, as the market later quieted even more. To counter this sluggish market, some producers tried to raise the prices, which ultimately stabilized.

The hurricane season in North America, which typically affects supply channels, had a limited impact on this sector. Despite steady consumer demand, subdued upstream cost support caused prices to fluctuate in the market. Additionally, a plant explosion at BASF's Ludwigshafen facility in Germany in August temporarily halted operations. While this incident led the company to declare force majeure for vitamin A and E production, However, it is unlikely to have a significant impact on vitamin prices in the long term but affected the supply outputs temporarily. Overall, mixed market sentiments were witnessed.

Biotin's price trajectory in the second quarter of the year 2024 was not much different from its performance in the first quarter of the year 2024. The market was observed to be more consolidated and range-bound this time around since the supply and demand dynamic suggested negligible modification in the upstream and downstream market equations.

The biotin market continued its reliance on the feedstock corn starch and other carbohydrate base materials prices. In Asian markets, particularly India and China, the biotin prices were found to mimic the sluggishness in the corn markets. Since the raw materials were available easily at affordable costs, the manufacturing costs remained muted for the major part.

At the same time, the downstream market demands were also very regular. The domestic market was still somewhat supportive; the export queries had taken a bit hit, especially from the European nations. Various logistical and supply related challenges were the roadblocks in the European trade equations. Overall, the markets there remained dull for the most part.

The US biotin market also didn't exude any desirable enthusiasm. With steady consumer demands and subdued upstream cost support, the biotin prices remained buoyant in the American markets as well. Overall, a tepid price curve was observed for biotin during the concerned time span.

Biotin or Vitamin B7’s production involves a fermentation process with suitable microorganisms and then further downstream steps of purification, condensation, etc. The efficiency and affordability of this process determine the upstream price trajectory for biotin in the international markets. Corn feed and other sugar sources that are used as base materials for fermentation processes also affect the pricing situation for biotin. During the first quarter of 2024, biotin prices mostly observed an upward-wavering trajectory.

Along with a rise in the feedstock costs, the downstream demands have been equally supportive of the rising market trajectory. Especially in the post-Covid era, people have started taking their health seriously. Along with the pharma, the nutraceutical industry has also been flourishing. The nutraceutical sector has emerged as one of the biggest consumers of biotin. With hair and skin issues rising in most populations of the world, biotin consumption has also been included as a supplement. Overall, positive market sentiments were witnessed in Q1’24.

The biotin market experienced some downsizing during the last quarter of the year 2023. The biggest downfall of the demands came from healthcare and the skincare sectors. Biotin, which is also popularly known as Vitamin B7, is produced using cyclic amines and potassium borohydride, and both feedstocks were readily available during the concerned period.

The industrial slump in the USA earlier this year because of weak economic circumstances in the region kept the unused stocks stacked up in inventories, and that further created cost pressure for suppliers. So, in order to vacate inventories and make space for fresh stocks the suppliers chipped down the biotin prices. Overall, dull and falling price trend were observed for biotin throughout the entire three-month span of Q4 of 2023.

Biotin belongs to the family of water-soluble B vitamins with excessive employability in the pharmaceutical and cosmetic industries. It is naturally obtained from food sources such as eggs, nuts, and vegetables and synthetically from the bacteria culture.

Biotin’s price trend, thus, are dictated by its industrial uses and methods of production. The cost of natural raw materials used in its production in India surged due to a variety of factors. The most significant contributor to this rise in prices was uneven rainfall and ill consequences of climate change observed in the agricultural sectors. To curb these rising rates of inflation in the food sector, the government took strict measures, such as an export ban, which helped stabilize the trajectory of the biotin price graph in the third quarter of 2023.

Asia

The price trend of biotin fluctuated throughout the first and second quarters of 2023, as there was a considerable decline in the demand from the downstream industries. In the first quarter, China strengthened its export rates and eased its trade policies that, boosted the international offtakes.

In the second quarter, however, the production activities declined along with the weak demand from the downstream industries and the low number of offtakes from the domestic and international traders. In addition to this, trade was also affected by the slow recovery of the Chinese economy after the pandemic and the ongoing struggling global markets due to the Russia-Ukraine crisis.

Europe

In European countries, the price trend of biotin showcased a mixed signal but majorly remained on the positive end as the imports from Asian countries became expensive due to the strengthening of Asian currency. In addition to this, the surge in demand from the end-user industries caused the level of inventories to decline and thus supported the rising trend of biotin prices. However, the trajectory of the biotin price trend slumped in the last phase of the second quarter.

The main causes of this decline were the reduction in the appetite of buyers, the rise in stockpiles of inventories, and the weak performance of the economy. In addition to this, inflation in food and energy prices also hampered the growth of the biotin price trend.

North America

The first quarter of 2023 proved to be unfavorable for the biotin market as its price trend declined consistently. The biotin market was adversely affected by the restricted trade, high inflation, and uncertainties in the energy production market caused by the Russia-Ukraine crisis.

In April, there was a slight rise in the prices as end-user industries presented large orders and slow supply chains failed to cater to this high demand. However, in the subsequent months, the decline in the prices of biotin was a direct consequence of the poor purchasing potential of buyers and high-interest rates.